Trial intelligence / Profile preview

CHILURSO: Ursodeoxycholic acid vs corticosteroids for cholestatic hepatitis induced by immune checkpoint inhibitors

2025-521317-50-00Phase 3Authorised

Sponsor: Centre Hospitalier Universitaire de Montpellier
Start: Oct 2025
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, randomised, open-label trial in cholestatic hepatitis comparing Ursodeoxycholic acid arm with Corticosteroid arm (2 arms). Planned start Oct 2025; status: authorised.

Drugs

ursodeoxycholic acidprednisone

Conditions

cholestatic hepatitis

Beyond the preview

Go deeper on 2025-521317-50-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-521317-50-00.